225 related articles for article (PubMed ID: 30506046)
1. Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease.
Laidlaw TM
World J Otorhinolaryngol Head Neck Surg; 2018 Sep; 4(3):162-168. PubMed ID: 30506046
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease.
Cahill KN; Laidlaw TM
Immunol Allergy Clin North Am; 2016 Nov; 36(4):681-691. PubMed ID: 27712763
[TBL] [Abstract][Full Text] [Related]
3. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
Buchheit KM; Cahill KN; Katz HR; Murphy KC; Feng C; Lee-Sarwar K; Lai J; Bhattacharyya N; Israel E; Boyce JA; Laidlaw TM
J Allergy Clin Immunol; 2016 May; 137(5):1566-1576.e5. PubMed ID: 26691435
[TBL] [Abstract][Full Text] [Related]
4. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
Laidlaw TM; Buchheit KM; Cahill KN; Hacker J; Cho L; Cui J; Feng C; Chen CC; Le M; Israel E; Boyce JA
J Allergy Clin Immunol; 2023 Sep; 152(3):700-710.e3. PubMed ID: 37068712
[TBL] [Abstract][Full Text] [Related]
5. [Advances in aspirin-exacerbated respiratory disease (AERD)].
Higashi N; Mitsui C; Taniguchi M
Nihon Rinsho; 2016 Oct; 74(10):1683-1687. PubMed ID: 30551280
[TBL] [Abstract][Full Text] [Related]
6. A trial of type 12 purinergic (P2Y
Laidlaw TM; Cahill KN; Cardet JC; Murphy K; Cui J; Dioneda B; Kothari P; Raby BA; Israel E; Boyce JA
J Allergy Clin Immunol; 2019 Jan; 143(1):316-324.e7. PubMed ID: 29890239
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil production of prostaglandin D
Feng X; Ramsden MK; Negri J; Baker MG; Payne SC; Borish L; Steinke JW
J Allergy Clin Immunol; 2016 Oct; 138(4):1089-1097.e3. PubMed ID: 27423494
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes.
Laidlaw TM; Kidder MS; Bhattacharyya N; Xing W; Shen S; Milne GL; Castells MC; Chhay H; Boyce JA
Blood; 2012 Apr; 119(16):3790-8. PubMed ID: 22262771
[TBL] [Abstract][Full Text] [Related]
9. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.
Eastman JJ; Cavagnero KJ; Deconde AS; Kim AS; Karta MR; Broide DH; Zuraw BL; White AA; Christiansen SC; Doherty TA
J Allergy Clin Immunol; 2017 Jul; 140(1):101-108.e3. PubMed ID: 28279492
[TBL] [Abstract][Full Text] [Related]
10. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
Parker AR; Ayars AG; Altman MC; Henderson WR
Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.
Laidlaw TM; Cutler AJ; Kidder MS; Liu T; Cardet JC; Chhay H; Feng C; Boyce JA
J Allergy Clin Immunol; 2014 Jun; 133(6):1692-701.e3. PubMed ID: 24486071
[TBL] [Abstract][Full Text] [Related]
12. Updates on immune mechanisms in aspirin-exacerbated respiratory disease.
Laidlaw TM; Boyce JA
J Allergy Clin Immunol; 2023 Feb; 151(2):301-309. PubMed ID: 36184313
[TBL] [Abstract][Full Text] [Related]
13. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
Liu T; Kanaoka Y; Barrett NA; Feng C; Garofalo D; Lai J; Buchheit K; Bhattacharya N; Laidlaw TM; Katz HR; Boyce JA
J Immunol; 2015 Oct; 195(8):3537-45. PubMed ID: 26342029
[TBL] [Abstract][Full Text] [Related]
14. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease.
Steinke JW; Negri J; Liu L; Payne SC; Borish L
J Immunol; 2014 Jul; 193(1):41-7. PubMed ID: 24890720
[TBL] [Abstract][Full Text] [Related]
15. Factors driving the aspirin exacerbated respiratory disease phenotype.
Steinke JW; Borish L
Am J Rhinol Allergy; 2015; 29(1):35-40. PubMed ID: 25590316
[TBL] [Abstract][Full Text] [Related]
16. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease.
Cardet JC; White AA; Barrett NA; Feldweg AM; Wickner PG; Savage J; Bhattacharyya N; Laidlaw TM
J Allergy Clin Immunol Pract; 2014; 2(2):208-13.. PubMed ID: 24607050
[TBL] [Abstract][Full Text] [Related]
17. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease.
Wang XS; Wu AY; Leung PS; Lau HY
Allergy; 2007 Jun; 62(6):620-7. PubMed ID: 17508965
[TBL] [Abstract][Full Text] [Related]
18. Platelets in patients with aspirin-exacerbated respiratory disease.
Laidlaw TM; Boyce JA
J Allergy Clin Immunol; 2015 Jun; 135(6):1407-14; quiz 1415. PubMed ID: 26051947
[TBL] [Abstract][Full Text] [Related]
19. Aspirin-exacerbated respiratory disease: evaluation and management.
Lee RU; Stevenson DD
Allergy Asthma Immunol Res; 2011 Jan; 3(1):3-10. PubMed ID: 21217919
[TBL] [Abstract][Full Text] [Related]
20. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
